Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Certified by Founder
Lodge
CanSense
start up
United Kingdom
- Swansea, Wales
- 09/03/2023
- Unknown
- $1,776,000
At CanSense we utilise cutting-edge data analytics and machine learning to maximise the performance of our blood test aimed at triaging patients at high risk of cancer.
- Industry Biotechnology Research
- Website https://cansenseltd.com/
- LinkedIn https://www.linkedin.com/company/cansense/
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)